HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cindy S Chu Selected Research

Primaquine

10/2021Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria.
12/2019Resolving the cause of recurrent Plasmodium vivax malaria probabilistically.
6/2019Tafenoquine and G6PD: a primer for clinicians.
1/2019Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion.
1/2019The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
1/2019Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
1/2019The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.
1/2019Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.
1/2019Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
10/2018Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cindy S Chu Research Topics

Disease

21Vivax Malaria
10/2021 - 01/2014
17Glucosephosphate Dehydrogenase Deficiency
03/2021 - 04/2015
16Hemolysis
01/2021 - 01/2014
13Malaria
03/2021 - 09/2011
6Infections
12/2019 - 05/2017
2Parasitemia
01/2019 - 10/2018
1Fever (Fevers)
10/2021
1Body Weight (Weight, Body)
10/2021
1Methemoglobinemia
10/2021
1Mental Disorders (Mental Disorder)
03/2021
1Psychotic Disorders (Schizoaffective Disorder)
03/2021
1Favism
01/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2020
1Kernicterus
01/2019
1Syphilis
01/2019
1Premature Birth (Birth, Premature)
01/2019
1Reinfection
01/2018
1Neonatal Hyperbilirubinemia
01/2018
1Poliomyelitis (Polio)
10/2016
1Measles
10/2016
1Diphtheria
10/2016
1Tetanus
10/2016
1Whooping Cough (Pertussis)
10/2016
1Mumps
10/2016
1Urinary Tract Infections (Urinary Tract Infection)
10/2015
1Spontaneous Abortion (Miscarriage)
05/2014

Drug/Important Bio-Agent (IBA)

20PrimaquineFDA Link
10/2021 - 01/2014
17Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
10/2021 - 04/2015
10Chloroquine (Aralen)FDA LinkGeneric
10/2021 - 01/2015
9Pharmaceutical PreparationsIBA
10/2021 - 01/2015
8tafenoquineIBA
03/2021 - 01/2017
6Antimalarials (Antimalarial Agents)IBA
01/2019 - 01/2014
3artenimol (dihydroartemisinin)IBA
10/2021 - 02/2017
3piperaquineIBA
10/2021 - 02/2017
3VaccinesIBA
10/2016 - 09/2011
2EnzymesIBA
01/2021 - 03/2018
2artemisinin (artemisinine)IBA
01/2020 - 10/2019
28-aminoquinolineIBA
01/2018 - 01/2014
18- (3- carboxy- 1- methylpropylamino)- 6- methoxyquinolineIBA
10/2021
1MethemoglobinIBA
10/2021
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2019
1ArtesunateIBA
10/2018
1DapsoneFDA Link
03/2018
1Oxidants (Oxidizing Agents)IBA
01/2018
1NADP (NADPH)IBA
02/2017
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
10/2016
1Rubella VaccineIBA
10/2016
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
10/2016
1gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA
10/2016
1Anti-Bacterial Agents (Antibiotics)IBA
10/2015
1Methylene Blue (Methylthioninium Chloride)FDA Link
01/2015

Therapy/Procedure

4Therapeutics
01/2021 - 01/2019
2Prenatal Care (Care, Prenatal)
01/2019 - 05/2014
2Secondary Prevention
01/2019 - 10/2016
1Contraindications
03/2021
1Chemoprevention
03/2021
1Duration of Therapy
01/2019
1Cesarean Section (Caesarean Section)
01/2019